Gemcitabine
specificA broad-spectrum antimetabolite and deoxycytidine analogue with antineoplastic activity. Upon administration, gemcitabine is converted into the active metabolites difluorodeoxycytidine diphosphate (dFdCDP) and difluorodeoxycytidine triphosphate (dFdCTP) by deoxycytidine kinase. dFdCTP competes with deoxycytidine triphosphate (dCTP) and is incorporated into DNA. This locks DNA polymerase thereby resulting in "masked termination" during DNA replication. On the other hand, dFdCDP inhibits ribonucl
48
Centers
0
Active Trials
$81M
Cancer Funding
Top Centers for Gemcitabine(48)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 68.2 |
| 2 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 67.4 |
| 3 | University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive Active Research Program | 66.7 |
| 4 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 66.0 |
| 5 | UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program | 65.3 |
| 6 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program | 64.5 |
| 7 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 63.8 |
| 8 | UCSF Helen Diller Family Comprehensive Cancer CenterSan Francisco, CA NCI Comprehensive Active Research Program | 63.1 |
| 9 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 62.3 |
| 10 | NCI Comprehensive Active Research Program | 61.6 |
| 11 | NCI Comprehensive Active Research Program | 60.9 |
| 12 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program | 60.2 |
| 13 | NCI Comprehensive Active Research Program | 59.4 |
| 14 | Wilmot Cancer Institute, UR MedicineRochester, NY NCI Clinical Active Research Program | 58.7 |
| 15 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 58.0 |
| 16 | UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive Active Research Program | 57.2 |
| 17 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 56.5 |
| 18 | Georgia Cancer Center, Augusta UniversityAugusta, GA Active Research Program | 55.8 |
| 19 | NCI Comprehensive Active Research Program | 55.1 |
| 20 | NCI Comprehensive Active Research Program | 54.3 |
| 21 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 53.6 |
| 22 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program | 52.9 |
| 23 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 52.1 |
| 24 | UofL James Graham Brown Cancer CenterLouisville, KY Active Research Program | 51.4 |
| 25 | Active Research Program | 50.7 |
| 26 | Hollings Cancer CenterCharleston, SC NCI Clinical Active Research Program | 49.9 |
| 27 | Stephenson Cancer CenterOklahoma City, OK NCI Clinical Active Research Program | 49.2 |
| 28 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 48.5 |
| 29 | Salk Institute Cancer CenterLa Jolla, CA NCI Basic_laboratory Active Research Program | 47.8 |
| 30 | Stony Brook Cancer CenterStony Brook, NY Active Research Program | 47.0 |
| 31 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 46.3 |
| 32 | Boston University Cancer CenterBoston, MA Active Research Program | 45.6 |
| 33 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive | 39.4 |
| 34 | Moffitt Cancer CenterTampa, FL NCI Comprehensive | 39.4 |
| 35 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive | 39.4 |
| 36 | NCI Clinical | 39.4 |
| 37 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive | 39.4 |
| 38 | Medical College of Wisconsin Cancer CenterMilwaukee, WI | 39.4 |
| 39 | University of Illinois Cancer CenterChicago, IL | 39.4 |
| 40 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive | 39.4 |
| 41 | Cancer Center at IllinoisUrbana, IL | 39.4 |
| 42 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL | 39.4 |
| 43 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ | 39.4 |
| 44 | Upstate Cancer CenterSyracuse, NY | 39.4 |
| 45 | University of Texas Medical Branch Cancer CenterGalveston, TX | 39.4 |
| 46 | Princess Margaret Cancer CentreToronto, ON | 39.4 |
| 47 | Louisiana Cancer Research CenterNew Orleans, LA | 39.4 |
| 48 | 39.4 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →